Monday, January 6, 2014

Can a Form Letter from FDA "Blow Your Mind"?

Adam Feuerstein appears to be a generally astute observer of the biotech scene. As a finance writer, he's accosted daily with egregiously hyped claims from small drug companies and their investors, and I think he tends to do an excellent job of spotting cases where breathless excitement is unaccompanied by substantive information.


However, Feuerstein's healthy skepticism seems to have abandoned him last year in the case of a biotech called Sarepta Therapeutics, who released some highly promising - but also incredibly limited - data on their treatment for Duchenne muscular dystrophy. After a disappointing interaction with the FDA, Sarepta's stock dropped, and Feuerstein appeared to realize that he'd lost some objectivity on the topic.


However, with the new year comes new optimism, and Feuerstein seems to be back to squinting hard at tea leaves - this time in the case of a form letter from the FDA.


He claims that the contents of the letter will "blow your mind". To him, the key passage is:


We understand that you feel that eteplirsen is highly effective, and may be confused by what you have read or heard about FDA's actions on eteplirsen. Unfortunately, the information reported in the press or discussed in blogs does not necessarily reflect FDA's position. FDA has reached no conclusions about the possibility of using accelerated approval for any new drug for the treatment of Duchenne muscular dystrophy, and for eteplirsen in particular.


Feuerstein appears to think that the fact that FDA "has reached no conclusions" may mean that it may be "changing its mind". To which he adds: "Wow!"
Adam Feuerstein: This time,
too much froth, not enough coffee?


I'm not sure why he thinks that. As far as I can tell, the FDA will never reach a conclusion like this before its gone through the actual review process. After all, if FDA already knows the answer before the full review, what would the point of the review even be? It would seem a tremendous waste of agency resources. Not to mention how non-level the playing field would be if some companies were given early yes/no decisions while others had to go through a full review.


It seems fair to ask: is this a substantive change by FDA review teams, or would it be their standard response to any speculation about whether and how they would approve or reject a new drug submission? Can Feuerstein point to other cases where FDA has given a definitive yes or no on an application before the application was ever filed? I suspect not, but am open to seeing examples.


A more plausible theory for this letter is that the FDA is attempting a bit of damage control. It is not permitted to share anything specific it said or wrote to Sarepta about the drug, and has come under some serious criticism for “rejecting” Sarepta’s Accelerated Approval submission. The agency has been sensitive to the DMD community, even going so far as to have Janet Woodcock and Bob Temple meet with DMD parents and advocates last February. Sarepta has effectively positioned FDA as the reason for it’s delay in approval, but no letters have actually been published, so the conversation has been a bit one-sided. This letter appears to be an attempt at balancing perspectives a bit, although the FDA is still hamstrung by its restriction on relating any specific communications.

Ultimately, this is a form letter that contains no new information: FDA has reached no conclusions because FDA is not permitted to reach conclusions until it has completed a fair and thorough review, which won't happen until the drug is actually submitted for approval.

We talk about "transparency" in terms of releasing clinical trials data, but to me there is a great case to be made for increase regulatory transparency. The benefits to routine publication of most FDA correspondence and meeting results (including such things as Complete Response letters, explaining FDA's thinking when it rejects new applications) would actually go a long way towards improving public understanding of the drug review and approval process.

6 comments:

online dissertation writing service said...

It is a great idea of the FDA advocating to abit of damage control. This is a informative post.Keep sharing more and more. Keep it up.

Thesis writing service said...

I really appreciate your post. Thanks for sharing such an useful information.

International business platform said...

Thank you for sharing such a informative information with us. Keep on sharing the blog like this.

robertinagosip said...

By visiting our site and/ or purchasing something from us, you engage in our “Service” and agree to be bound by the following terms and conditions all descriptions of products or Buy mobile phone socket holder pricing are subject to change at anytime without notice, at the sole discretion of us any products, services, information click our services.

Buy handles yoga pull rope elastic fitness
Buy electric pulse back and neck massager
Buy back stretch equipment massager
Buy portable sonar fish finders online
Buy bum bags hip money belt travel
Buy silver fanny pack female belt bag

Gadgetseur said...

Gadgetseur online international eCommerce electronic product buy online like that Buy active stylus pen online, Vehicle smart dash cam pro at best price, Waterproof USB charging fingerprint lock smart padlock fingerprint and many more item which offers you a lot of great offers Buy waterproof USB charging Fingerprint Lock and discounts on gadgets and other items and surely. However the best online sites at your country specific website? Get to know the top international Gadgetseur company for electronic gadgets and expand your options mutlifold they have also got weekly deals and as well as good amount of offers Buy vehicle smart dash cam pro online, Buy waterproof USB charging Fingerprint Lock, Active stylus pen to make visit their website and can order everything available.

danielamadilyna said...

Clear Estate Solutions company don’t focus on the House for sale in California, Sell house without realtor California we focus on the relationship and what we can offer to the customer. Clear Estate Solutions company there are so many ways to Sell house without realtor Oregon and Seller financing in California, Real estate investing in California our company help to buy, sell, and rent to know about more below....

We are here to provide you with creative ways to maximize the return on your investment or to solve any real estate problems you may have Foreclosure service California, Rent to own homes California, Owner financing in Washington Clear Estate Solutions company help buy, sell, and rent always are easy way get more detail click our link.